Enanta Pharmaceuticals
ENTA
#7360
Rank
C$0.61 B
Marketcap
C$21.24
Share price
5.92%
Change (1 day)
135.50%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total assets

Total assets on the balance sheet as of September 2025 : C$0.38 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total assets are C$0.38 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Enanta Pharmaceuticals - Total assets on balance sheet (from 2011 to 2025)

Total assets by year

Year Total assets Change
2024-09-30C$0.50 B-18.9%
2023-09-30C$0.62 B21.46%
2022-09-30C$0.51 B-7.06%
2021-09-30C$0.55 B-13.95%
2020-09-30C$0.64 B-0.28%
2019-09-30C$0.64 B21.95%
2018-09-30C$0.53 B31.27%
2017-09-30C$0.40 B9.44%
2016-09-30C$0.37 B13.01%
2015-09-30C$0.32 B88.12%
2014-09-30C$0.17 B44.22%
2013-09-30C$0.12 B135.22%
2012-09-30C$51.33 M89.78%
2011-09-30C$27.05 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
AbbVie
ABBV
C$184.79 B 47,596.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$266.10 B 68,583.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$34.31 B 8,756.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$178.78 B 46,045.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$133.71 B 34,412.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$148.06 B 38,117.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland